Marcel Blommers

Title: Marcel Blommers: Innovator in RNA Interference

Introduction

Marcel Blommers is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of RNA interference, holding a total of 4 patents. His work focuses on developing novel compounds and compositions that enhance the efficacy of RNAi agents.

Latest Patents

One of his latest patents involves the creation of 3' end caps for RNAi agents used in RNA interference. This patent discloses novel compounds and compositions that comprise an RNAi agent with a unique 3' end cap. The invention also details processes for making these compositions and their applications in mediating RNA interference. Another significant patent addresses organic compounds designed to treat the hepatitis B virus. This disclosure includes compositions that feature a HBV RNAi agent, which consists of both sense and anti-sense strands. These strands are designed to form a blunt-ended duplex, with specific modifications to enhance their effectiveness.

Career Highlights

Marcel Blommers is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to further his research and development in the field of RNA interference, contributing to advancements in therapeutic applications.

Collaborations

Throughout his career, Marcel has collaborated with several talented individuals, including Jeremy Lee Baryza and Cesar Fernandez. These collaborations have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Marcel Blommers is a distinguished inventor whose work in RNA interference has the potential to significantly impact the treatment of viral infections. His innovative patents and collaborations highlight his commitment to advancing medical science.